Glytec
Founded in 2006, Glytec is the pioneer and leader in diabetes therapy management software, enabling healthcare organizations to standardize acute and chronic care, and achieve best practice for glucose control. The company’s comprehensive eGlycemic Management System® (eGMS®) has been proven to dramatically reduce the drivers of cost and clinical variation, including hypoglycemia, readmissions, length of stay, complications and A1C levels. Its efficacy and safety have been validated by more than 60 research studies. eGMS® centers on an FDA-cleared insulin dosing solution that supports personalized intravenous and subcutaneous therapy for adult and pediatric populations.